In 2023, the share of Italy's scientific publications in pharmacy among the world's top 10% cited stood at an undisclosed rate. Forecasts from 2024 to 2028 predict a gradual decline from 11.84% to 11.75%, showcasing a minor decrease. This decline is indicative of a challenging competitive environment in scientific pharmacy publications, with year-on-year variations being minimal. The compound annual growth rate (CAGR) over the period from 2024 to 2028 will likely show a slight downward trend.

Future trends to be observed include:

The impact of collaborative international research efforts on maintaining and improving citation impact.
The influence of Italy's investment in pharmaceutical research and development on publication reach and quality.
The role of emerging technologies and interdisciplinary approaches in boosting scientific output and citations.